Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × entinostat × 90 days × Clear all

Sponsor

Conditions

Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Recurrence 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Anus Neoplasms 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡